GV Portfolio 2026

23 companies backed by GV, including OpenEvidence, Nectar Social, Blockaid. Each links to its full verified cap-table syndicate.

GV accounts for 145 tracked companies with verified cap-table data, 145 of which disclose round sizes totalling $33B. The median disclosed raise is $130M, and the largest is Isomorphic Labs at $2.1B, ahead of SambaNova Systems ($1.4B) and Snyk ($1.2B).

The names that recur most often on these portfolio cap tables are GV (145 companies), Andreessen Horowitz (13 companies), ARCH Venture Partners (11 companies), Alexandria Venture Investments (10 companies), Sequoia Capital (9 companies), Polaris Partners (9 companies). By latest disclosed round, the market skews Series B (35), Series A (30), Series C (30), Series D (24).

Best funded GV companies

  1. Isomorphic Labs — $2.1B (latest: Series B)
  2. SambaNova Systems — $1.4B (latest: Series E)
  3. Snyk — $1.2B (latest: Series F)
  4. Harvey — $1.2B (latest: Series F)
  5. Treeline Biosciences — $1.1B (latest: Series A)
  6. Farmers Business Network — $900M
  7. Cockroach Labs — $801M (latest: Series F)
  8. EQRx — $750M (latest: Series B)
  9. Sana Biotechnology — $700M (latest: IPO)
  10. Wonder — $650M (latest: Series D)
  11. You.com — $650M (latest: Series C)
  12. Recursive — $650M (latest: Series F)
  13. Harness — $570M (latest: Series D)
  14. OnDeck — $529M (latest: Other Equity)
  15. Fog Pharmaceuticals — $506M (latest: Series E)

GV (Google Ventures) — related firms and companies (56)

GV (Google Ventures) profile · All research reports